Colchicine in Atrial Fibrillation to Prevent Stroke
Status:
Completed
Trial end date:
2020-11-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of performing a randomized
controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at
reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).